-+ 0.00%
-+ 0.00%
-+ 0.00%

Press Release: Edgewise Therapeutics Completes Sale of Sevasemten for Up to $2.65 Billion, Strengthening Balance Sheet and Centering Company Focus on Cardiovascular Pipeline

Dow Jones·07/13/2026 12:30:00

Please log in to view news